Basile Siewe1, Joey T Pham, Mardge Cohen, Nancy A Hessol, Alexandra Levine, Otoniel Martinez-Maza, Alan Landay. 1. aRush University Medical Center bDepartments of Medicine, Stroger Hospital and Rush University, Chicago, Illinois cDepartment of Clinical Pharmacy, University of California San Francisco, San Francisco dCity of Hope National Medical Center, Duarte eUCLA AIDS Institute, University of California, California, USA.
Abstract
OBJECTIVES: In antiretroviral therapy (ART)-treated patients, to determine if AIDS-related non-Hodgkin lymphoma (AIDS-NHL) is preceded by: elevated frequency of potentially malignant abnormal activated/germinal center-like B cells, elevated serum prevalence of B-cell stimulatory Toll-like receptor (TLR) ligands resulting from HIV infection-associated microbial translocation, dysregulated B-cell TLR expression/signaling, and perturbations in the frequency of immunoregulatory cells. DESIGN: A case-control study nested with a cohort study of HIV-infected women. METHODS: Prediagnostic AIDS-NHL cases (n = 12, collected 1-12 months before diagnosis) and controls (n = 42) from the Women's Interagency HIV Study cohort, were matched for HIV and ART status, age, race, and CD4 lymphocyte count. Serum levels of TLR ligands, the prevalence of malignancy-associated abnormal activated/germinal center-like (CD19CD10CD71CD86AID) B cells, TLR2 expression on B cells, expression of TLR2-modulating micro-RNA, and the frequency of regulatory T and B cells were assessed. RESULTS: Diagnosis of AIDS-NHL was preceded by a significantly elevated frequency of activated/germinal center-like CD19CD10CD71CD86AID B cells (P = 0.0072), elevated serum prevalence of the TLR2 ligand, and significantly elevated B-cell TLR2 expression (P = 0.0015), positively correlating with the frequency of activated/germinal center-like B cells (rho = 0.7273, P = 0.0144). In cases, a purified subset of activated/germinal center-like B cells exhibited decreased expression of microRNAs that modulate TLR2 signaling, including miR-21, 146a, 146b, and 155. Finally, cases also exhibited significantly elevated frequencies of antitumor immunity inhibitory regulatory B cells (P = 0.0024), but not regulatory T cells. CONCLUSIONS: Our findings suggest that increased microbial translocation and dysregulated TLR expression/signaling, coupled with an elevated frequency of regulatory B cells, precede the diagnosis of AIDS-NHL in HIV-infected ART-treated patients.
OBJECTIVES: In antiretroviral therapy (ART)-treated patients, to determine if AIDS-related non-Hodgkin lymphoma (AIDS-NHL) is preceded by: elevated frequency of potentially malignant abnormal activated/germinal center-like B cells, elevated serum prevalence of B-cell stimulatory Toll-like receptor (TLR) ligands resulting from HIV infection-associated microbial translocation, dysregulated B-cell TLR expression/signaling, and perturbations in the frequency of immunoregulatory cells. DESIGN: A case-control study nested with a cohort study of HIV-infectedwomen. METHODS: Prediagnostic AIDS-NHL cases (n = 12, collected 1-12 months before diagnosis) and controls (n = 42) from the Women's Interagency HIV Study cohort, were matched for HIV and ART status, age, race, and CD4 lymphocyte count. Serum levels of TLR ligands, the prevalence of malignancy-associated abnormal activated/germinal center-like (CD19CD10CD71CD86AID) B cells, TLR2 expression on B cells, expression of TLR2-modulating micro-RNA, and the frequency of regulatory T and B cells were assessed. RESULTS: Diagnosis of AIDS-NHL was preceded by a significantly elevated frequency of activated/germinal center-like CD19CD10CD71CD86AID B cells (P = 0.0072), elevated serum prevalence of the TLR2 ligand, and significantly elevated B-cell TLR2 expression (P = 0.0015), positively correlating with the frequency of activated/germinal center-like B cells (rho = 0.7273, P = 0.0144). In cases, a purified subset of activated/germinal center-like B cells exhibited decreased expression of microRNAs that modulate TLR2 signaling, including miR-21, 146a, 146b, and 155. Finally, cases also exhibited significantly elevated frequencies of antitumor immunity inhibitory regulatory B cells (P = 0.0024), but not regulatory T cells. CONCLUSIONS: Our findings suggest that increased microbial translocation and dysregulated TLR expression/signaling, coupled with an elevated frequency of regulatory B cells, precede the diagnosis of AIDS-NHL in HIV-infected ART-treatedpatients.
Authors: Mercy Guech-Ongey; Edgar P Simard; William F Anderson; Eric A Engels; Kishor Bhatia; Susan S Devesa; Sam M Mbulaiteye Journal: Blood Date: 2010-09-02 Impact factor: 22.113
Authors: Morgan A Marks; Charles S Rabkin; Eric A Engels; Evan Busch; William Kopp; Helen Rager; James J Goedert; Anil K Chaturvedi Journal: AIDS Date: 2013-01-28 Impact factor: 4.177
Authors: Elizabeth Crabb Breen; Shehnaz K Hussain; Larry Magpantay; Lisa P Jacobson; Roger Detels; Charles S Rabkin; Richard A Kaslow; Daina Variakojis; Jay H Bream; Charles R Rinaldo; Richard F Ambinder; Otoniel Martinez-Maza Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-04-28 Impact factor: 4.254
Authors: Shehnaz K Hussain; Weiming Zhu; Shen-Chih Chang; Elizabeth Crabb Breen; Elena Vendrame; Larry Magpantay; Dan Widney; Daniel Conn; Mary Sehl; Lisa P Jacobson; Jay H Bream; Steven Wolinsky; Charles R Rinaldo; Richard F Ambinder; Roger Detels; Zuo-Feng Zhang; Otoniel Martínez-Maza Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-12-18 Impact factor: 4.254
Authors: Marta Epeldegui; Dharma R Thapa; Justin De la Cruz; Scott Kitchen; Jerome A Zack; Otoniel Martínez-Maza Journal: PLoS One Date: 2010-07-06 Impact factor: 3.240
Authors: Alison J Rodger; Rebecca Lodwick; Mauro Schechter; Steven Deeks; Janaki Amin; Richard Gilson; Roger Paredes; Elzbieta Bakowska; Frederik N Engsig; Andrew Phillips Journal: AIDS Date: 2013-03-27 Impact factor: 4.177
Authors: Daniel A Duprez; Jacqueline Neuhaus; Lewis H Kuller; Russell Tracy; Waldo Belloso; Stephane De Wit; Fraser Drummond; H Clifford Lane; Bruno Ledergerber; Jens Lundgren; Daniel Nixon; Nicholas I Paton; Ronald J Prineas; James D Neaton Journal: PLoS One Date: 2012-09-10 Impact factor: 3.240
Authors: Marta Epeldegui; David V Conti; Yu Guo; Wendy Cozen; Manuel L Penichet; Otoniel Martínez-Maza Journal: Sci Rep Date: 2019-06-28 Impact factor: 4.996